A Study to Evaluate Effectiveness of Sublobar Dissection in Patients With Non-small Cell Lung Cancer

NCT03427567 | Completed

• 1 other identifier: TJ-LC-01
• Study Type: observational
• Target: 3,902
• Locations: 1 country
• Sites: 10

Brief Summary

A study to evaluate effectiveness of sublobar dissection in patients with non-small cell lung cancer

Conditions

Non-small Cell Lung Cancer

Keywords

Chinese; real-world evidences; NSCLC; sublobar dissection

Outcome Measures

Primary Outcomes (1)

• Overall survival

  Overall survival

  2014 - 2017

Secondary Outcomes (1)

• Overall survivals in subgroups

  2014 - 2017

Other Outcomes (4)

• Impact factors of overall survival

  2014 - 2017

• Death rates after surgeries

  2014 - 2017

• Impact factors of death rates after surgeries

  2014 - 2017

Study Arms (1)

Sublobar dissection

Chinese NSCLC patients who received sublobar dissection

Procedure: Sublobar dissection

Interventions

Sublobar dissection PROCEDURE

Sublobar dissection plus lymphadenectomy

Also known as: Surgeries

Sublobar dissection

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Chinese patients with pathological diagnosed non-small cell lung cancer who received sublobar dissection and lymphadenectomy

You may qualify if:

• Patients \>= 18 years old;
• Patients who received sublobar dissection from 2014 to 2017 (segment dissection/wedge dissection/segment and wedge dissections);
• Patients who received selective or systematic lymphadenectomy;
• Pathologically diagnosed patients with non-small cell lung cancer;
• Pathological staging: I, II

You may not qualify if:

• Patients who received cancer treatments before surgeries (adjuvant therapies including chemotherapies, radiotherapies, target therapies);
• Patients who received late-phase or intolerant palliative lobectomy or compromise sublobar dissection;

Sponsors & Collaborators

• Tongji Hospital: lead
• LinkDoc Technology (Beijing) Co. Ltd.: collaborator

Study Sites (10)

China-Japan Friendship Hospital

Beijing, Beijing Municipality, 100029, China

Location

China PLA General Hospital

Beijing, Beijing Municipality, 100853, China

Location

Henan cancer hospital

Zhengzhou, Henan, 450003, China

Location

Tongji Hospital Affiliated to Huazhong Technology Hospital

Wuhan, Hubei, 430030, China

Location

Jiangsu cancer hospital

Nanjing, Jiangsu, 210009, China

Location

Xi'an Tangdu Hospital

Xi'an, Shaanxi, 710000, China

Location

Shanghai Chest Hospital

Shanghai, Shanghai Municipality, 200030, China

Location

Huaxi Hospital Affiliated to Sichuan University

Chengdu, Sichuan, 610041, China

Location

Tianjin Chest Hospital

Tianjin, Tianjin Municipality, 300051, China

Location

First Hospital Affiliated to Zhejiang University

Hangzhou, Zhejiang, 310003, China

Location

MeSH Terms

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

Surgical Procedures, Operative

Condition Hierarchy (Ancestors)

Carcinoma, Bronchogenic; Bronchial Neoplasms; Lung Neoplasms; Respiratory Tract Neoplasms; Thoracic Neoplasms; Neoplasms by Site; Neoplasms; Lung Diseases; Respiratory Tract Diseases

Study Officials

• Xiangning Fu, PhD

  Tongji Hospital Affiliated to Tongji Medical College Huazhong Technology University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor

Study Record Dates

• First Submitted: February 2, 2018
• First Posted: February 9, 2018
• Study Start: December 1, 2017
• Primary Completion: December 1, 2017
• Study Completion: March 30, 2018
• Last Updated: May 21, 2018

Record last verified: 2018-05

Data Sharing

• IPD Sharing: Will not share

Locations

CN (10)